Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Programmed Death-Ligand 1 Expression and EGFR Mutations in Multifocal Lung Cancer.

The Annals of thoracic surgery - 1 Feb 2018

Haratake Naoki, Toyokawa Gouji, Takada Kazuki, Kozuma Yuka, Matsubara Taichi, Takamori Shinkichi, Akamine Takaki, Katsura Masakazu, Shoji Fumihiro, Okamoto Tatsuro, Oda Yoshinao, Maehara Yoshihiko

Abstract excerpt

BACKGROUND: Little is known about the programmed death-ligand 1 (PD-L1) expression in multifocal lung cancer, such as the expression in multiple primary lung cancer and pulmonary metastasis. In this translational study, we investigated PD-L1 expression and its relationship with the epidermal growth factor receptor (EGFR) mutation status in resected multifocal lung cancer. METHODS: The PD-L1 expression in 152...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to B7-H1 Antigen
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA, Neoplasm

Share to ErbB Receptors

Share to Gene Expression Regulation, Neoplastic

Share to Immunohistochemistry

Share to Lung Neoplasms

Share to Neoplasm Staging

Source

Identifiers

PMID: 29254651
DOI: 10.1016/j.athoracsur.2017.09.025

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Programmed Death-Ligand 1 Expression and EGFR Mutations in Multifocal Lung Cancer.PMID 29254651Read ↗

Use of Oncogenic Driver Mutations in Staging of Multiple Primary Lung Carcinomas: A Single-Center Experience.Semantic proximity Read ↗

Driver Mutation Analysis and PD-L1 Expression in Synchronous Double Primary Lung Cancer.Semantic proximity Read ↗

PD-L1 expression in lung cancer and its correlation with driver mutations: a meta-analysis.Semantic proximity Read ↗

Significance of programmed death-ligand 1 expression in resected lung cancer and its relationship with EGFR mutation.Semantic proximity Read ↗

Concomitant EGFR mutation and ALK rearrangement in multifocal lung adenocarcinoma: a case report.Semantic proximity Read ↗

[Expression of PD-1/PD-L1 in lung adenocarcinoma and correlation with epidermal growth factor receptor mutation status].Semantic proximity Read ↗

Unusual metachronous lung adenocarcinomas harboring EGFR L858R/T790M mutations: A case report.Semantic proximity Read ↗

Concomitant EGFR Mutation and EML4-ALK Rearrangement in Lung Adenocarcinoma Is More Frequent in Multifocal LesionsSemantic proximity Read ↗

Lesions in patients with multifocal adenocarcinoma are more frequently in the right upper lobes.Semantic proximity Read ↗

Discrepancy in Programmed Cell Death-Ligand 1 Between Primary and Metastatic Non-small Cell Lung CancerSemantic proximity Read ↗

Concordant and Discordant EGFR Mutations in Patients With Multifocal Adenocarcinomas: Implications for EGFR-Targeted Therapy.Semantic proximity Read ↗

PD-L1 expression according to the EGFR status in primary lung adenocarcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.